ADC Therapeutics SA

NYSE:ADCT

Pharmaceutical Preparations·EPALINGES, V8

CEO

Mallik Ameet

CFO

Carmona Jose

Financials

8 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/6/24	→
↓

Earnings Releases (8-K)

12 shown

Filed	Period
1/8/26	Q4 FY2026	→
11/10/25	Q4 FY2025	→
10/14/25	Q3 FY2025	→
8/12/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
3/27/25	Q1 FY2025	→
↓

News (8-K)

16 shown

Filed	Type	Description
2/23/26	Agreement	Entry into a Material Definitive Agreement	→
1/12/26	Reg FD	Regulation FD Disclosure	→
12/5/25	Other	Other Events	→
9/30/25	Reg FD	Regulation FD Disclosure	→
6/12/25	Agreement	Entry into a Material Definitive Agreement	→
6/5/25	Vote	FORM 8K	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/12/25	424B3	424B3	→
12/9/25	S-3/A	FORM S-3/A	→
11/10/25	S-3	S-3	→
9/30/25	S-8	S-8	→
8/12/25	S-8	S-8	→
7/10/25	424B3	424B3	→
↓

Filing History(396 filings)

TypeDateAccessionPeriodSize

8-K

Feb 23, 2026

0000950103-26-002466FORM 8-K

Feb 18, 2026

352.4 KB

Feb 18, 2026

0001628280-26-009283FORM 4

Feb 13, 2026

6.4 KB

Feb 18, 2026

0001628280-26-009282FORM 4

Feb 13, 2026

6.4 KB

Feb 18, 2026

0001628280-26-009280FORM 4

Feb 13, 2026

6.4 KB

Feb 18, 2026

0001628280-26-009278FORM 4

Feb 13, 2026

6.5 KB

Feb 18, 2026

0001628280-26-009275FORM 4

Feb 13, 2026

7.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0000947871-26-000186

—

14.8 KB

SCHEDULE 13G/A

Feb 17, 2026

0000902664-26-001151

—

11.8 KB

SCHEDULE 13G

Feb 17, 2026

0001193125-26-054764

—

128.6 KB

SCHEDULE 13G/A

Feb 17, 2026

0001104659-26-016431

—

14.2 KB

SCHEDULE 13G/A

Feb 13, 2026

0001104659-26-015265

—

16.9 KB

8-K

Jan 12, 2026

0000950103-26-000349FORM 8-K

Jan 12, 2026

18.7 MB

8-K

Jan 8, 2026

0001628280-26-0013868-K

Jan 8, 2026

164.4 KB

EFFECT

Dec 12, 2025

9999999995-25-003703

—

1.7 KB

424B3

Dec 12, 2025

0000950103-25-016077FORM 424B3

—

314.8 KB

Dec 9, 2025

0001628280-25-056172FORM 4

Dec 6, 2025

4.7 KB

Dec 9, 2025

0001628280-25-056171FORM 4

Dec 6, 2025

4.8 KB

Dec 9, 2025

0001628280-25-056170FORM 4

Dec 6, 2025

4.7 KB

Dec 9, 2025

0001628280-25-056169FORM 4

Dec 6, 2025

4.7 KB

Dec 9, 2025

0001628280-25-056168FORM 4

Dec 6, 2025

4.8 KB

S-3/A

Dec 9, 2025

0000950103-25-015918FORM S-3/A

—

61.9 KB

8-K

Dec 5, 2025

0000950103-25-015818FORM 8-K

Dec 3, 2025

187.0 KB

SCHEDULE 13G/A

Nov 13, 2025

0001104659-25-111601

—

16.9 KB

S-3

Nov 10, 2025

0000950103-25-014521FORM S-3

—

554.0 KB

10-Q

Nov 10, 2025

0001628280-25-05109510-Q

Sep 30, 2025

7.5 MB

25 filings shown

Filed	Form	Description
4/21/25	DEF 14A	DEF 14A	→
4/21/25	DEFA14A	FORM DEFA14A	→
4/9/25	PRE 14A	PRE 14A	→
9/23/24	DEFA14A	FORM DEFA14A	→
9/23/24	DEF 14A	DEF 14A	→
9/13/24	PRE 14A	FORM PRE 14A	→
↓

ADC Therapeutics SA

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(396 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/18/26	4	4	→
2/18/26	4	4	→
2/18/26	4	4	→
2/18/26	4	4	→
2/18/26	4	4	→
12/9/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/12/25	EFFECT	EFFECT	→
↓